NovoCure (NVCR) Cash & Equivalents (2014 - 2026)
NovoCure (NVCR) posted Cash & Equivalents of $93.7 million for Q2 2026, up 7.05% sequentially from $87.5 million in Q1 2026, and down 37.38% YoY from $149.6 million in Q2 2025.
NovoCure (NVCR) Cash & Equivalents (2014 - 2026) Analysis & Trends
NovoCure has reported Cash & Equivalents for 13 years, with the latest figure at $93.7 million in Q2 2026.
- Quarterly Cash & Equivalents fell 37.38% year-over-year to $93.7 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $93.7 million (down 37.38% YoY) and the FY2025 annual result came in at $93.5 million, down 42.88% from the prior year.
- Cash & Equivalents improved to $93.7 million in Q2 2026 per NVCR's latest filing, from $87.5 million in the prior quarter.
- Over five years, Cash & Equivalents peaked at $453.8 million in Q1 2024 and troughed at $87.5 million in Q1 2026.
- A 5-year average of $195.4 million and a median of $164.3 million in 2024 frame the typical range for Cash & Equivalents.
- The sharpest annual moves came in 2024 and 2025: Cash & Equivalents jumped 144.01% in 2024, then sank 71.95% in 2025.
- Over 5 years, Cash & Equivalents stood at $115.3 million in 2022, then surged by 108.82% to $240.8 million in 2023, then plunged by 32.0% to $163.8 million in 2024, then sank by 42.88% to $93.5 million in 2025, then grew by 0.16% to $93.7 million in 2026.
- According to Business Quant data, Cash & Equivalents over the past three periods registered $93.7 million, $87.5 million, and $93.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 5.10 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 3.39 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 1.95 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 2.91 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 1.11 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 3.25 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 482.30 Mn |
| 10 | NovoCure | 2.06 Bn | 1.62 Bn | 142.48 Mn | 93.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 93.70 Mn |
| Mar 31, 2026 | 87.53 Mn |
| Dec 31, 2025 | 93.55 Mn |
| Sep 30, 2025 | 342.12 Mn |
| Jun 30, 2025 | 149.62 Mn |
| Mar 31, 2025 | 127.28 Mn |
| Dec 31, 2024 | 163.77 Mn |
| Sep 30, 2024 | 185.42 Mn |
| Jun 30, 2024 | 164.80 Mn |
| Mar 31, 2024 | 453.76 Mn |
| Dec 31, 2023 | 240.82 Mn |
| Sep 30, 2023 | 154.86 Mn |
| Jun 30, 2023 | 156.98 Mn |
| Mar 31, 2023 | 185.96 Mn |
| Dec 31, 2022 | 115.33 Mn |
| Sep 30, 2022 | 243.81 Mn |
| Jun 30, 2022 | 367.01 Mn |
| Mar 31, 2022 | 190.74 Mn |
| Dec 31, 2021 | 208.80 Mn |
| Sep 30, 2021 | 689.84 Mn |